
    
      The investigators plan to randomise 120 patients of biopsy proven NASH into cases and control
      groups.

      Baseline investigations:

      Clinical characteristics

        -  Age

        -  Gender

        -  Anthropometry (BMI, waist circumference, waist- hip ratio, triceps skin fold thickness,
           mid arm circumference)

        -  Alcohol intake should be nil

      Laboratory characteristics

        -  Hemogram, INR, KFT

        -  LFT (especially ALT, GGT) , APRI (AST to platelet ratio)

        -  Fasting Lipid Profile

        -  Other possible etiologies of liver disease (viral markers, ferritin, ANA, IgG,
           ceruloplasmin )

        -  HOMA-IR (II)

        -  Serum uric acid levels Liver stiffness

        -  Fibroscan

        -  MR elastography Radiological characteristics

        -  USG abdomen Variceal status by UGI endoscopy Alpha fetoprotein Pro- inflammatory markers

        -  TNF-alpha, IL-6, adiponectin, leptin and osteopontin Liver biopsy and NAS score
    
  